Total Payments
$1,204
2024 Payments
$28.95
Companies
10
Transactions
52
Medicare Patients
683
Medicare Billing
$58,308
Payment Breakdown by Category
Food & Beverage$1,204 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,204 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $271.28 | 16 | $0 (2020) |
| Shire North American Group Inc | $219.19 | 13 | $0 (2019) |
| Kala Pharmaceuticals, Inc. | $174.39 | 4 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $155.43 | 4 | $0 (2019) |
| Bausch & Lomb Americas Inc. | $125.00 | 1 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $119.78 | 7 | $0 (2017) |
| ABBVIE INC. | $49.21 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $35.26 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $32.35 | 2 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $22.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.95 | 1 | ABBVIE INC. ($28.95) |
| 2023 | $180.52 | 4 | Bausch & Lomb Americas Inc. ($125.00) |
| 2020 | $13.42 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($13.42) |
| 2019 | $434.23 | 14 | Kala Pharmaceuticals, Inc. ($174.39) |
| 2018 | $290.49 | 17 | Bausch & Lomb, a division of Bausch Health US, LLC ($166.27) |
| 2017 | $256.78 | 15 | Valeant Pharmaceuticals North America LLC ($119.78) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: EYE CARE | ||||||
| 12/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: TEPEZZA | ||||||
| 11/30/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: EYE CARE | ||||||
| 11/16/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/10/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: TEPEZZA | ||||||
| 02/20/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: OCULAR | ||||||
| 10/28/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), LOTEMAX SM, BESIVANCE | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $99.56 | General |
| Category: Ophthalmology | ||||||
| 09/10/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $119.16 | General |
| Category: OCULAR | ||||||
| 08/20/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), PROLENSA, LOTEMAX SM | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/02/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), XELPROS | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Ophthalmology | ||||||
| 06/10/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: OPTHALMICS | ||||||
| 05/17/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: OCULAR | ||||||
| 05/06/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/01/2019 | Novartis Pharmaceuticals Corporation | DUREZOL (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/15/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), LOTEMAX, PROLENSA | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/13/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/08/2019 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: OCULAR | ||||||
| 01/07/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: OPTHALMICS | ||||||
| 12/24/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | PROLENSA (Drug), ALREX, LOTEMAX GEL | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BESIVANCE (Drug), VYZULTA | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/12/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: OPTHALMICS | ||||||
| 09/25/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), BESIVANCE, ZYLET | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/07/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: OPTHALMICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 66 | 69 | $18,202 | $9,291 |
| 2020 | 10 | 617 | 661 | $200,120 | $49,017 |
Total Patients
683
Total Services
730
Medicare Billing
$58,308
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 13 | 16 | $7,529 | $3,935 | 52.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 30 | 30 | $6,394 | $3,119 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,861 | $1,495 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,419 | $741.62 | 52.3% |
| 66984 | Removal of cataract with insertion of lens | Facility | 2020 | 33 | 55 | $110,000 | $22,571 | 20.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 267 | 267 | $33,375 | $11,677 | 35.0% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2020 | 25 | 31 | $17,050 | $7,181 | 42.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 60 | 64 | $5,440 | $1,864 | 34.3% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 74 | 74 | $11,100 | $1,249 | 11.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 27 | 27 | $4,050 | $1,171 | 28.9% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 41 | 42 | $4,095 | $1,149 | 28.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2020 | 27 | 38 | $7,030 | $917.22 | 13.0% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 42 | 42 | $6,300 | $745.41 | 11.8% |
| 92250 | Photography of the retina | Office | 2020 | 21 | 21 | $1,680 | $492.57 | 29.3% |
About Dr. Gail Royal, M.D
Dr. Gail Royal, M.D is a Ophthalmology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851310783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gail Royal, M.D has received a total of $1,204 in payments from pharmaceutical and medical device companies, with $28.95 received in 2024. These payments were reported across 52 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,204).
As a Medicare-enrolled provider, Royal has provided services to 683 Medicare beneficiaries, totaling 730 services with total Medicare billing of $58,308. Data is available for 2 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Myrtle Beach, SC
- Active Since 07/19/2006
- Last Updated 09/05/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1851310783
Products in Payments
- XIIDRA (Drug) $219.19
- INVELTYS (Drug) $174.39
- PROLENSA (Drug) $149.54
- VYZULTA (Drug) $146.48
- MIEBO (Drug) $125.00
- BROMSITE (Drug) $114.00
- BESIVANCE (Drug) $95.04
- LUMIGAN (Drug) $49.21
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $41.43
- TEPEZZA (Drug) $35.26
- DUREZOL (Drug) $32.35
- Tecnis 1-piece IOL (Device) $22.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Myrtle Beach
Dr. Carl Sloan, M.d, M.D
Ophthalmology — Payments: $100,317
Ophthalmology $100,317
Dr. Neil Griffin, Md, MD
Ophthalmology — Payments: $6,570
Ophthalmology $6,570
Thomas D'orazio, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $3,195
Ophthalmology $3,195
Stephen Phillips, M.d, M.D
Ophthalmology — Payments: $2,733
Ophthalmology $2,733
Dr. Shawn Riley, Md, MD
Ophthalmology — Payments: $2,361
Ophthalmology $2,361
Reuben Tipton, Iii, M.d, M.D
Ophthalmology — Payments: $921.16
Ophthalmology $921.16